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Abstract
Background: Cardiac sympathetic afferent reflex (CSAR) contributes to sympathetic activation and angiotensin II (Ang II) in
paraventricular nucleus (PVN) augments the CSAR in vagotomized (VT) and baroreceptor denervated (BD) rats with chronic
heart failure (CHF). This study was designed to determine whether it is true in intact (INT) rats with CHF and to determine
the effects of cardiac and baroreceptor afferents on the CSAR and sympathetic activity in CHF.
Methodology/Principal Findings: Sham-operated (Sham) or coronary ligation-induced CHF rats were respectively subjected
to BD+VT, VT, cardiac sympathetic denervation (CSD) or INT. Under anesthesia, renal sympathetic nerve activity (RSNA) and
mean arterial pressure (MAP) were recorded, and the CSAR was evaluated by the RSNA and MAP responses to epicardial
application of capsaicin. Either CSAR or the responses of RSNA, MAP and CSAR to Ang II in PVN were enhanced in CHF rats
treated with BD+VT, VT or INT. Treatment with VT or BD+VT potentiated the CSAR and the CSAR responses to Ang II in both
Sham and CHF rats. Treatment with CSD reversed the capsaicin-induced RSNA and MAP changes and the CSAR responses to
Ang II in both Sham and CHF rats, and reduced the RSNA and MAP responses to Ang II only in CHF rats.
Conclusions: The CSAR and the CSAR responses to Ang II in PVN are enhanced in intact CHF rats. Baroreceptor and vagal
afferent activities inhibit CSAR and the CSAR responses to Ang II in intact Sham and CHF rats.
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Introduction
Excessive sympathetic activity contributes to haemodynamic
deterioration in chronic heart failure (CHF) [1,2]. Cardiac
sympathetic afferent reflex (CSAR) is known to increase
sympathetic activity and blood pressure [3] and the enhanced
CSAR is involved in the sympathetic over-activation in CHF [4,5].
The CSAR can be induced by stimulation of cardiac sympathetic
afferents with exogenous chemicals such as capsaicin, bradykinin,
adenosine and hydrogen peroxide or endogenous chemicals
released from myocardium during myocardial ischemia [3]. The
enhanced CSAR in CHF attributes to the increased activity of
cardiac sympathetic afferents and the potentiated central gain of
this reflex [4].
Paraventricular nucleus (PVN) of hypothalamus is an important
component of the central neurocircuitry of the CSAR [6,7] and
plays an important role in regulating the sympathetic and
cardiovascular activity via its projections to the rostral ventrolat-
eral medulla and intermediolateral column of the spinal cord [8].
Lots of signal molecules or enzymes in the PVN are involved in
mediating or modulating the CSAR such as superoxide anions [9],
NAD(P)H oxidase [10], hydrogen peroxide [11], GABA [12], c-
Src [13], tumor necrosis factor a and interleukin 1b [14]. It has
been found that angiotensin II (Ang II) type 1 (AT1) receptor
expression is increased in the PVN in CHF rats [15]. Ang II in the
PVN augments the CSAR and increases the sympathetic outflow
and blood pressure, which is mediated by AT1 receptors in the
PVN in CHF rats [16]. The effects of Ang II in the PVN on the
CSAR and sympathetic activation are mediated by the NAD(P)H
oxidase originated superoxide anions in the PVN in CHF rats and
renovascular hypertensive rats [17,18]. However, these experi-
ments were carried out in animals with bilateral cervical vagotomy
(VT) and baroreceptor denervation (BD) to minimize the
confounding effects of baroreceptor and vagal afferent activities
on the CSAR and sympathetic drive in these experiments. One
key issue to be resolved is whether the sympatho-excitatory CSAR
is still enhanced in intact CHF rats.
It is known that the sympatho-inhibitory baroreceptor reflex is
diminished or desensitized whereas the sympatho-excitatory
CSAR and arterial chemoreceptor reflex are enhanced in CHF
[3,5]. Augmented input from cardiac sympathetic afferents
enhances the arterial chemoreceptor reflex in normal rats [19]
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and CHF rats [22]. On the other hand, stimulation of cardiac
vagal afferent endings evokes reflex hypotension and bradycardia
[23]. However, the effects of the arterial baroreceptor and vagal
afferents on the enhanced CSAR in CHF rats are unknown.
Furthermore, the impacts of arterial baroreceptor and vagal inputs
on the effects of Ang II in the PVN in CHF are unknown. The
aims of the present study were to determine whether the CSAR
was enhanced in intact CHF rats, and whether the baroreceptor
and vagal afferents inhibited the enhanced CSAR and the CSAR-
enhancing effects of Ang II in the PVN in CHF rats.
Materials and Methods
Experiments were carried out on male Sprague-Dawley rats
weighing between 300 and 400 g. The procedures were approved by
t h eE x p e r i m e n t a lA n i m a lC a r ea n dU s eC o m m i t t e eo fN a n j i n g
Medical University (No. 20100097) and complied with the Guide for
the Care and Use of Laboratory Animals (NIH publication no. 85–
23, revised 1996). The rats were housed individually in standard
laboratory cages with ad libitum access to standard chow and tap
water under controlled temperature and a 12:12-h dark-light cycle.
CHF model
Myocardialinfarctionisacommoncauseindrivingtheoccurrence
of ventricular dysfunction and heart failure [24]. The CHF in the
present study was induced by coronary artery ligation with sterile
techniques as previously reported [25]. Briefly, the rats were
anesthetized with sodium pentobarbital (50 mg kg
21, i.p.). The rats
were randomlysubjected to the ligation ofthe leftanterior descending
coronary artery or sham operation. The sham-operated (Sham) rats
were treated the same as the coronary ligation rats except that their
coronary arteries were not ligated. The criteria for CHFisthat the left
ventricle end-diastolic pressure (LVEDP) is higher than 12 mm Hg
and the maximum of the first differentiation of left ventricular
pressure (+dP/dt max) is 40% lower than that of Sham rats.
General procedures of acute experiment
Acute experiment was carried out 7 weeks after coronary
ligation or sham surgery. Each rat was anaesthetized with
intraperitoneal injection of urethane (800 mg kg
21) and a-
chloralose (40 mg kg
21). Supplemental doses of urethane and a-
chloralose were administered to maintain an adequate depth of
anesthesia during experiments. The trachea was cannulated and
connected with a rodent ventilator (683; Harvard Apparatus Inc.,
USA) for mechanical ventilation. A catheter connected with a
pressure transducer was placed into the right carotid artery to
measure the arterial pressure.
Baroreceptor denervation and vagotomy
Vagotomy (VT) and arterial baroreceptor denervation (BD)
were carried out as previously reported [9,26]. The bilateral
cervical vagi, carotid sinus nerves and other visible nerve fibers in
carotid sinus areas were sectioned. The carotid bifurcation and
common carotid arteries were stripped of adventitial tissues from
4 mm below the bifurcation to 4 mm above. The vessels were
painted with 10% phenol solution to destroy remnants of nerve
fibers in these areas. Baroreceptor denervation was assumed to be
complete if heart rate (HR) changed less than 5 beats min
21 in
response to intravenous injection of phenylephrine (20 mgk g
21).
Cardiac sympathetic denervation
Bilateral cardiac sympathetic denervation (CSD) companied
with stellate ganglionectomy was carried out as previously
reported [27]. A thoracotomy was performed by cutting the
sternum directly on the midline from the manubrium to just
above the xiphoid process. All nerve branches running into the
stellate ganglion between the first and second ribs beneath the
parietal pleura were isolated and sectioned. The ganglion was
excised and the T1–T4 sympathetic rami were transected.
Renal sympathetic nerve activity recording
The renal sympathetic nerve activity (RSNA) was recorded as
previously reported [28]. After the left renal nerve was distally
cut, the nerve was placed onto a pair of silver recording
electrodes and was soaked in warm mineral oil. The signal was
amplified (61000) using an AC/DC differential amplifier (3000;
A–M Systems Inc., Sequim, WA, USA) with a band-pass filter
(low frequency 30 Hz, high frequency 3 kHz). The amplified and
filtered signal was integrated (10 ms time constant). The baseline
noise was determined after section of the central end of the renal
nerve at the end of the experiment and was subtracted from the
integrated RSNA. The raw RSNA, integrated RSNA, arterial
pressure, mean artery pressure (MAP) and HR were simulta-
neously recorded on a PowerLab data acquisition system (8SP;
ADInstruments, Sydney, Australia) and stored on disk until
analyzed.
Evaluation of CSAR
The heart was exposed and the pericardium was removed
through the thoracotomy. A piece of filter paper (363 mm)
containing capsaicin (1.0 nmol in 2.0 ml) was applied to the
epicardial surface of the anterior wall of the left ventricle for 1 min
to induce the CSAR. Then, the epicardium was rinsed three times
with 10 ml of warm normal saline (38uC). The CSAR was
evaluated by the RSNA and MAP responses to epicardial
application of capsaicin [26].
PVN microinjection
The rats were placed in a stereotaxic frame (Stoelting, Chicago,
IL, USA). The stereotaxic coordinates for the PVN are 1.8 mm
caudal to bregma, 0.4 mm lateral to the mid-line and 7.9 mm
ventral to the dorsal surface according to the stereotaxic atlas of
Paxinos & Watson (2005). Microinjection into the PVN was
performed with a glass micropipette (50 mm tip diameter). The
microinjection volume for each side of the PVN was 50 nl and the
microinjections were completed within 1 min. At the end of the
experiment, the same volume of Evans Blue dye was injected into
the microinjection site for histological verification. The data from
the rats whose microinjection sites were outside the PVN were
excluded for analysis [29].
Protocols
Acute experiments were carried out 7 weeks after coronary
ligation or sham surgery. Either Sham or CHF rats were randomly
divided into four groups, which were subjected to the VT, BD+VT
or CSD, or were kept intact (INT). A 60-min stabilization period
was allowed before determination of the CSAR induced by
epicardial application of capsaicin (1.0 nmol, n=6 for each group)
or the PVN microinjection of Ang II (0.3 nmol) followed by CSAR
determination 2 min after Ang II (n=6 for each group). For
evaluation of the CSAR, the RSNA and MAP were determined
before epicardial application and 20 s after epicardial application
by averaging 20 s of the values.
Drugs
Capsaicin and Ang II were purchased from Sigma.
Cardiovascular Reflex in Chronic Heart Failure
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The values were expressed as the means 6 S.E.M. Comparisons
between two observations in the same animal were assessed by
Student’s paired t test. One-way or two-way ANOVA followed by
the Newman-Keuls test for post hoc analysis was used when
multiple comparisons were made. Statistical significance was taken
at a value of P,0.05.
Results
Anatomical and hemodynamic data
The mean infarct area was 34.0 % of the left ventricle in CHF
rats but no obvious infarct was found in Sham rats. The heart
weight and the heart-to-body weight ratio were increased in CHF
rats, suggesting myocardial hypertrophy in the non-infarcted
region of the myocardium. The systolic arterial pressure, left
ventricle peak systolic pressure, developed pressure and +dP/dtmax
deceased, but LVEDP increased in CHF rats (Table 1).
MAP and HR
No significant difference in MAP and HR was found 1 hour
after treatment with INT, VT, BD+VT or CSD between Sham
rats and CHF rats. However, the CSD treatment decreased the
HR in CHF rats but not in Sham rats (Table 2).
Baseline CSAR
Representative recordings in Fig. 1 showed the baseline CSAR
change (RSNA and MAP responses to epicardial application of
capsaicin) in Sham rats and CHF rats. Capsaicin increased the
RSNA and MAP in INT, VT or BD+VT rats, but decreased the
RSNA and MAP in CSD rats. In INT-, VT- or BD+VT-treated
rats, the excitatory responses of capsaicin were greater in CHF rats
than Sham rats. However, in CSD-treated rats, the inhibitory
responses of capsaicin were not significantly greater in CHF rats
than Sham rats. In either Sham or CHF rats, the RSNA and MAP
responses to capsaicin were greater in VT-treated rats than INT
rats. In CHF rats, the responses were greater in BD+VT-treated
rats than either INT rats or VT rats (Fig. 2).
RSNA and MAP responses to Ang II
In INT, VT or BD+VT-treated rats, the PVN microinjection of
Ang II caused greater increases in the RSNA and MAP in CHF
rats than that in Sham rats. Compared with intact Sham or intact
CHF rats, VT or BD+VT only caused a tendency in enhancing
the effects of Ang II on the RSNA and MAP (P.0.05), while CSD
attenuated Ang II-induced increases in RSNA and MAP in CHF
rats but not in Sham rats (Fig. 3).
CSAR responses to Ang II
The PVN microinjection of Ang II significantly augmented the
RSNA and MAP responses to epicardial application of capsaicin
in Sham rats treated with BD+VT and in CHF rats treated with
INT, VT or BD+VT. The enhanced RSNA and MAP responses
to capsaicin after Ang II were significantly greater in CHF rats
than Sham rats (Table 3). The effects of Ang II in the PVN on the
RSNA and MAP responses to capsaicin were augmented by VT,
and further augmented by BD+VT. Ang II had no significant
effects on the inhibitory RSNA and MAP responses to capsaicin in
either Sham or CHF rats treated with CSD (Fig. 4).
Discussion
The primary findings in the present study are that the CSAR is
enhanced not only in CHF rats with bilateral vagotomy and
arterial baroreceptor denervation, but also in intact CHF rats. The
vagotomy and baroreceptor denervation augment the basal CSAR
and the enhanced CSAR responses to Ang II in the PVN. The
cardiac sympathetic denervation reversed the RSNA and MAP
responses to capsaicin in both Sham and CHF rats. After cardiac
sympathetic denervation, Ang II had no significantly effects on the
CSAR in both Sham and CHF rats, but the Ang II-induced
excitatory RSNA and MAP responses were reduced in CHF rats
but not in Sham rats. These results indicate that the CSAR is also
enhanced in intact CHF rats and the inputs of the arterial
baroreceptor and vagal afferents inhibit the CSAR and the
enhanced CSAR responses to Ang II in the PVN.
The cardiac sympathetic afferent stimulation increases sympa-
thetic outflow and blood pressure in vagotomized and barorecep-
tor denervated dogs [30], rats [31] and cats [7]. It has been found
that epicardial application of hydrogen peroxide (H2O2) in cervical
vagotomized cat increases MAP, HR and LV dP/dt, while H2O2
Table 1. Anatomic and hemodynamic data in Sham and CHF
rats.
Sham CHF
n4 8 4 8
Body weight (g) 358.266.7 351.766.9
Heart weight (g) 1.360.1 1.560.1 *
Heart weight/body weight (g/kg) 3.560.2 4.360.2 *
Infarct size (% LV area) 0 34.062.3 *
Systolic pressure (mm Hg) 127.064.6 111.864.3 *
Diastolic pressure (mm Hg) 75.562.9 76.162.8
Mean arterial pressure (MAP, mm Hg) 94.663.9 89.463.7
Heart rate (HR, beats/min) 376.968.1 383.367.2
LV systolic pressure (LVSP, mm Hg) 134.564.0 114.664.9 *
LV end-diastolic pressure (LVEDP, mm
Hg)
0.360.9 15.060.9 *
+LV dP/dtmax (mm Hg/sec) 3510.56106.7 1930.8689.3 *
LV, left ventricle; +LV dP/dtmax, maximum of the first differentiation of left
ventricular pressure. Values are mean 6 SE.
*P,0.05 compared with Sham rats.
doi:10.1371/journal.pone.0025784.t001
Table 2. The MAP and HR in Sham and CHF rats 1 hour after











CSD 368.769.3 354.8610.5 *
Values are mean 6 SE. n=12 for each group.
*P,0.05 compared with INT.
doi:10.1371/journal.pone.0025784.t002
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Furthermore, epicardial application of H2O2 in cats with T1–T4
ganglionectomy not only decreases MAP, HR and LV dP/dt, but
also abolishes the excitatory effects of H2O2. These results suggest
that activation of cardiac sympathetic afferents evokes cardiac
excitatory and pressor responses, while activation of cardiac vagal
afferents elicits inhibitory responses in normal cats [32]. Our
previous studies have shown that the CSAR is enhanced in CHF
rats [33] and renovascular hypertensive rats [28] and the
enhanced CSAR partially contributes to sympathetic activation
Figure 1. Representative tracings showing the CSAR induced by epicardial application of capsaicin in intact Sham rat, intact CHF
rat, BD+VT-treated CHF rat and CSD-treated CHF rat. BD+VT, baroreceptor denervation plus vagotomy; CSD, cardiac sympathetic denervation.
doi:10.1371/journal.pone.0025784.g001
Figure 2. The CSAR induced by epicardial application of capsaicin in Sham and CHF rats with INT, VT, BD+VT or CSD (n = 6 for each
group). Values are mean6SE. *P,0.05 compared with Sham rats; {P,0.05 compared with INT; {P,0.05 compared with VT. INT, intact; BD,
baroreceptor denervation; VT, vagotomy; CSD, cardiac sympathetic denervation.
doi:10.1371/journal.pone.0025784.g002
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the PVN are involved in the enhanced CSAR in CHF rats
[15,17,25] and hypertensive rats [13,18,29]. However, all these
studies were carried out in vagotomized and baroreceptor
denervated CHF or hypertensive rats. The present study was
designed to determine whether the CSAR is enhanced in intact
rats with CHF and whether the afferent activities of arterial
baroreceptor and vagi inhibit the CSAR.
It is known that the cardiac afferent fibers travel with both
cardiac sympathetic nerves and vagi [34]. The CSAR was
enhanced in CHF rats with BD+VT, which is similar to our
previous report [33]. Importantly, the CSAR was enhanced in
intact CHF rats, suggesting that the enhanced CSAR also partially
contribute to the sympathetic overdrive in intact CHF rats. The
VT or BD+VT potentiated the RSNA and MAP responses to
capsaicin in both Sham and CHF rats, suggesting that the afferent
activities of arterial baroreceptor and vagi inhibit the CSAR. The
CSD treatment reversed the RSNA and MAP responses to
capsaicin in both Sham and CHF rats, suggesting that vagal
afferent activities inhibit the sympathetic outflow and decrease
blood pressure. Compared with Sham rats, the excitatory RSNA
and MAP responses to capsaicin were enhanced in VT-treated
CHF rats, but the inhibitory RSNA and MAP responses to
capsaicin were not enhanced in CSD-treated CHF rats. These
results indicate that the excitatory reflex mechanism mediated by
sympathetic afferents prevails over the inhibitory mechanism
mediated by vagal afferents.
AT1 receptor blockers (ARBs) and angiotensin-converting
enzyme (ACE) inhibitors have been used to treat CHF [35,36].
It has been shown that enhanced angiotensin in the PVN mediates
the increased RSNA and AT1 receptors are up-regulated in the
PVN in rats with CHF [37]. In CHF rats with BD+VD,
microinjection of losartan, an antagonist of AT1 receptors, into
the PVN abolished the CSAR and decreased the RSNA and
MAP, while Ang II potentiated the CSAR and increased RSNA
and MAP which is abolished by losartan [16]. In the present study,
the increases in RSNA and MAP induced by the PVN
microinjection of Ang II as well as the enhancement in the CSAR
Figure 3. Effects of the paraventricular nucleus (PVN) microinjection of angiotensin II on the RSNA and MAP in Sham and CHF rats
with INT, VT, BD+VT, or CSD (n = 6 for each group). Values are mean6SE. *P,0.05 compared with Sham rats; {P,0.05 compared with INT.
INT, intact; BD, baroreceptor denervation; VT, vagotomy; CSD, cardiac sympathetic denervation.
doi:10.1371/journal.pone.0025784.g003
Table 3. Effects of PVN microinjection of saline or Ang II on the capsaicin-induced CSAR in Sham and CHF rats.
Groups RSNA change, % MAP change, mmHg
Saline Ang II Saline Ang II
Sham
INT 7.461.0 8.161.1 3.160.6 4.660.5
VT 13.761.9{ 14.762.6{ 5.560.9{ 8.161.0{
BD+VT 14.661.8{ 21.861.8*{{ 6.160.6{ 11.961.4*{{
CSD 23.260.8{ 23.461.2{ 21.260.3{ 22.060.5{
CHF
INT 12.961.0# 20.462.7*# 5.360.5# 7.560.6*#
VT 20.261.1{# 28.462.6*{# 8.860.8{# 12.760.9*{#
BD+VT 27.461.5{{# 39.061.4*{{# 12.961.4{# 18.361.8*{{#
CSD 23.361.0{ 24.361.3{ 21.260.4{ 22.760.9{
Values are mean 6 SE. n=6 for each group.
*P,0.05 compared with saline.
{P,0.05 compared with INT.
{P,0.05 compared with VT.
# P,0.05 compared with Sham.
doi:10.1371/journal.pone.0025784.t003
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VT or BD+VT significantly augmented the CSAR responses to
Ang II but only induced a tendency in increasing RSNA and MAP
responses to Ang II in both Sham and CHF rats. In both CSD-
treated Sham and CHF rats, Ang II had no significantly effects on
the CSAR and capsaicin still induced inhibitory RSNA and MAP
responses. However, the Ang II-induced excitatory RSNA and
MAP responses were reduced in CSD-treated CHF rats but not in
CSD-treated Sham rats. These results suggest that the excitatory
effects of Ang II in the PVN on the RSNA, MAP and CSAR are
still greater in intact CHF rats than intact Sham rats, and that the
baroreceptor and vagal afferent activities inhibit the effects of Ang
II on the CSAR in both Sham and CHF rats. The role of Ang II in
the PVN in increasing the RSNA and MAP partially attributes to
its CSAR-enhancing effect. These results are supported by our
recent findings that the firings of capsaicin-sensitive neurons in the
PVN are greater in rats with BD+VT, VT or BD than intact rats
after epicardial application of capsaicin, and that electrical
stimulation of the vagal afferents inhibits the firings of capsaicin-
sensitive neurons in the PVN in normal rats [38].
In conclusion, the CSAR is enhanced in intact CHF rats. The
activities of the arterial baroreceptor and vagal afferents inhibit the
CSAR and the enhanced CSAR responses to Ang II in the PVN.
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